Are you curious about where the best EVA heart products come from? With so many factories in China, finding the right one can feel overwhelming. Understanding the top manufacturers not only helps you make informed decisions but also ensures you get quality products that meet your needs. Imagine having access to the best options, saving time and money while ensuring superior quality. Ready to discover the leading EVA heart factories in China? Let’s dive in and explore the top contenders that can elevate your business and product offerings!
永仁心医疗|植入式左心室辅助装置|人工心脏|EVAHEART
Product Details: evaheart® left ventricular assist device, approved by NMPA for long-term treatment and short-term support indications.
Technical Parameters:
– NMPA approved
– Implantable left ventricular assist device
Application Scenarios:
– Heart failure treatment
– Cardiac support during surgery
Pros:
– Innovative design for heart failure
– Provides life-saving support
Cons:
– Requires surgical implantation
– Potential for device-related complications
Evaheart Unveils Its Latest Cutting-Edge EVA-Pulsar™ Artificial Heart
Product Details: EVA-Pulsar™ Ventricular Assist Device, second artificial heart product by Evaheart Medical.
Technical Parameters:
– Weight: 262 grams
– Pulse pressure difference: 20-30mmHg
Application Scenarios:
– Patients requiring ventricular assistance
– Heart failure patients
Pros:
– 60% lighter than the first-generation model
– Closely resembles normal human physiology
Cons:
– Limited information on long-term effects
– Still undergoing clinical trials in the U.S.
“Made in Chongqing” Artificial Hearts to Be Officially Used
Product Details: EVAHEART artificial heart, named ‘implanted ventriculus sinister auxiliary system’, approved for clinical use in China.
Technical Parameters:
– Internal blood pump with pump cable
– Artificial blood vessels and external controller
Application Scenarios:
– Heart failure patients requiring assistance with blood circulation
– First home-made artificial heart implantation operation in China
Pros:
– Achieved 100% success rate in clinical trials
– Zero death and no device-related serious complications
Cons:
– Technically demanding with strict requirements on pump operation
– Potential risks if biocompatibility is not maintained
[Long-term outcome of EVAHEART I implantable ventricular … – PubMed
Product Details: EVAHEART I implantable ventricular assist device for the treatment of end-stage heart failure.
Technical Parameters:
– Flow rates between 3.2-4.5 L/min
– Power consumption of 3-9 W
Application Scenarios:
– Patients with end-stage heart failure
– Patients requiring long-term mechanical circulatory support
Pros:
– Significantly improves survival rates
– Effective in treating critically ill patients
Cons:
– Risk of drive cable infection
– Requires careful monitoring and follow-up
Milestone: Evaheart I is China’s first homemade artificial heart
Product Details: Evaheart I is China’s first domestically developed artificial heart, cleared for marketing by regulators in Chongqing, Sichuan province.
Technical Parameters:
– First homemade artificial heart in China
– Developed by Chongqing Evaheart Medical Device Co. Ltd.
Application Scenarios:
– Cardiovascular treatments
– Patients with severe heart conditions
Pros:
– Domestically developed technology
– Potentially more accessible for Chinese patients
Cons:
– Limited information on long-term performance
– New technology may face initial skepticism
Artificial heart gets green light to go on market
Product Details: HeartCon is China’s first implantable left ventricular assist device, also known as the ‘rocket heart’, developed by Rocor Medical Technology Co.
Technical Parameters:
– Implantable left ventricular assist device
– Magneto hydrodynamic levitation technologies
Application Scenarios:
– Treatment for advanced heart failure
– Used in parallel with the heart to pump blood
Pros:
– First domestically made artificial heart in China
– Successfully completed 50 clinical trials
Cons:
– Limited to patients with advanced heart failure
– Requires surgical implantation
Evaheart | ichongqing
Product Details: EVA-Pulsar™ Artificial Heart by Evaheart
Technical Parameters:
– Cutting-edge technology
– Designed for artificial heart applications
Application Scenarios:
– Cardiac patients requiring artificial heart solutions
– Medical research and development
Pros:
– Innovative design
– Potential to improve patient outcomes
Cons:
– Still in development phase
– May have high costs associated with production
Flights to Mainland China | EVA Air
Product Details: EVA Air flights to Mainland China offer various cabin classes including Economy, Premium Economy, and Business Class with competitive pricing and world-class service.
Technical Parameters:
– Flight routes from major US cities to Mainland China
– Prices starting from USD 1,087
Application Scenarios:
– Traveling for business or leisure to Mainland China
– Exploring major cities like Beijing and Shanghai
Pros:
– Multiple cabin class options for different budgets
– World-class service and comfort
Cons:
– Prices may vary based on availability and surcharges
– Limited flight dates available for some routes
China artificial heart developer raises $100m | AVCJ
Product Details: China-based medical device manufacturer Evaheart has developed an artificial heart and raised close to USD 100m in funding.
Technical Parameters:
– USD 100m funding
– Series A investment
Application Scenarios:
– Cardiac support for patients
– Medical device innovation
Pros:
– Significant funding for development
– Partnership with established vaccine developer
Cons:
– Limited information on technical specifications
– Potential market competition
Artificial heart gets green light to go on market – China Daily
Product Details: HeartCon, China’s first implantable left ventricular assist device, also known as ‘rocket heart’, developed by Rocor Medical Technology Co.
Technical Parameters:
– Implantable left ventricular assist device
– Magneto hydrodynamic levitation technologies
Application Scenarios:
– Treatment for patients with advanced heart failure
– Used as a bridge to heart transplantation
Pros:
– First domestically made artificial heart in China
– Successfully completed 50 clinical trials
Cons:
– Limited long-term data on effectiveness
– Potential for complications associated with implantation
Related Video
Comparison Table
Company | Product Details | Pros | Cons | Website |
---|---|---|---|---|
永仁心医疗|植入式左心室辅助装置|人工心脏|EVAHEART | evaheart® left ventricular assist device, approved by NMPA for long-term treatment and short-term support indications. | – Innovative design for heart failure – Provides life-saving support | – Requires surgical implantation – Potential for device-related complications | www.evaheart.com.cn |
Evaheart Unveils Its Latest Cutting-Edge EVA-Pulsar™ Artificial Heart | EVA-Pulsar™ Ventricular Assist Device, second artificial heart product by Evaheart Medical. | – 60% lighter than the first-generation model – Closely resembles normal human physiology | – Limited information on long-term effects – Still undergoing clinical trials in the U.S. | www.ichongqing.info |
“Made in Chongqing” Artificial Hearts to Be Officially Used | EVAHEART artificial heart, named ‘implanted ventriculus sinister auxiliary system’, approved for clinical use in China. | – Achieved 100% success rate in clinical trials – Zero death and no device-related serious complications | – Technically demanding with strict requirements on pump operation – Potential risks if biocompatibility is not maintained | www.ichongqing.info |
[Long-term outcome of EVAHEART I implantable ventricular … – PubMed | EVAHEART I implantable ventricular assist device for the treatment of end-stage heart failure. | – Significantly improves survival rates – Effective in treating critically ill patients | – Risk of drive cable infection – Requires careful monitoring and follow-up | pubmed.ncbi.nlm.nih.gov |
Milestone: Evaheart I is China’s first homemade artificial heart | Evaheart I is China’s first domestically developed artificial heart, cleared for marketing by regulators in Chongqing, Sichuan province. | – Domestically developed technology – Potentially more accessible for Chinese patients | – Limited information on long-term performance – New technology may face initial skepticism | www.bioworld.com |
Artificial heart gets green light to go on market | HeartCon is China’s first implantable left ventricular assist device, also known as the ‘rocket heart’, developed by Rocor Medical Technology Co. | – First domestically made artificial heart in China – Successfully completed 50 clinical trials | – Limited to patients with advanced heart failure – Requires surgical implantation | global.chinadaily.com.cn |
Evaheart | ichongqing | EVA-Pulsar™ Artificial Heart by Evaheart | – Innovative design – Potential to improve patient outcomes | – Still in development phase – May have high costs associated with production |
Flights to Mainland China | EVA Air | EVA Air flights to Mainland China offer various cabin classes including Economy, Premium Economy, and Business Class with competitive pricing and worl… | – Multiple cabin class options for different budgets – World-class service and comfort | – Prices may vary based on availability and surcharges – Limited flight dates available for some routes |
China artificial heart developer raises $100m | AVCJ | China-based medical device manufacturer Evaheart has developed an artificial heart and raised close to USD 100m in funding. | – Significant funding for development – Partnership with established vaccine developer | – Limited information on technical specifications – Potential market competition |
Artificial heart gets green light to go on market – China Daily | HeartCon, China’s first implantable left ventricular assist device, also known as ‘rocket heart’, developed by Rocor Medical Technology Co. | – First domestically made artificial heart in China – Successfully completed 50 clinical trials | – Limited long-term data on effectiveness – Potential for complications associated with implantation | www.chinadaily.com.cn |
Frequently Asked Questions (FAQs)
What are EVA heart factories in China?
EVA heart factories in China specialize in producing ethylene-vinyl acetate (EVA) products, often used in various applications like footwear, toys, and packaging. These factories focus on creating high-quality EVA materials that are lightweight, flexible, and durable.
Why is EVA popular in manufacturing?
EVA is popular because it offers excellent cushioning, shock absorption, and resistance to UV light and weathering. This makes it ideal for products that require durability and comfort, such as sports shoes and protective gear.
How are EVA products made?
EVA products are made by blending ethylene and vinyl acetate in specific ratios, then heating and molding the mixture into desired shapes. The process can vary depending on the product, but it generally involves extrusion or injection molding techniques.
What industries use EVA products?
EVA products are widely used in various industries, including footwear, automotive, packaging, and sports equipment. Their versatility and performance make them suitable for applications ranging from shoe soles to insulation materials.
Are EVA products environmentally friendly?
EVA is considered more environmentally friendly than some alternatives, as it is non-toxic and can be recycled. However, the environmental impact depends on the manufacturing processes and disposal methods, so it’s essential to choose products from responsible manufacturers.